Quadramet

Active Ingredient(s): Samarium-153 Lexidronam
FDA Approved: * March 28, 1997
Pharm Company: * CYTOGEN
Category: Cancer

Samarium (153Sm) lexidronam (chemical name Samarium-153-ethylene diamine tetramethylene phosphonate, abbreviated Samarium-153 EDTMP, trade name Quadramet) is a chelated complex of a radioisotope of the element samarium with EDTMP. It is used to treat pain when cancer has spread to the bone.[1][2] It is injected into a vein and distributed throughout the body, where it is preferentially absorbed in areas where cancer has invaded the bone. The radioisotope 153Sm... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Quadramet 50 mci/Ml Intravenous Injection, Solution

NDC: 11994-016

Labeler:

Lantheus Medical Imaging, Inc.

Quadramet 50 mci/Ml Intravenous Injection, Solution

NDC: 57902-860

Labeler:

Jazz Pharmaceuticals, Inc.